Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	Alpha-2A adrenergic receptor
Species	Homo sapiens (Human)
Gene	ADRA2A
Synonym	alpha2D alpha2A-AR alpha2A-adrenoceptor alpha2A-adrenergic receptor alpha2A Alpha-2AAR Adra-2 Adra-2a ADRA2 ADRA2R Adrenergic alpha 2A receptor adrenergic receptor Alpha-2 adrenergic receptor subtype C10 Alpha-2A adrenoceptor Alpha-2A adrenoreceptor [ Show all ]
Disease	Attention deficit hyperactivity disorder Sexual dysfunction Pain
Length	450
Amino acid sequence	MGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFTSRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSIVHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIITVWVISAVISFPPLISIEKKGGGGGPQPAEPRCEINDQKWYVISSCIGSFFAPCLIMILVYVRIYQIAKRRTRVPPSRRGPDAVAAPPGGTERRPNGLGPERSAGPGGAEAEPLPTQLNGAPGEPAPAGPRDTDALDLEESSSSDHAERPPGPRRPERGPRGKGKARASQVKPGDSLPRRGPGATGIGTPAAGPGEERVGAAKASRWRGRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLTAVGCSVPRTLFKFFFWFGYCNSSLNPVIYTIFNHDFRRAFKKILCRGDRKRIV
UniProt	P08913
Protein Data Bank	N/A
GPCR-HGmod model	P08913
3D structure model	This predicted structure model is from GPCR-EXP P08913.
BioLiP	N/A
Therapeutic Target Database	T11448
ChEMBL	CHEMBL1867
IUPHAR	25
DrugBank	BE0000289

Ligand

Name	MDMA
Molecular formula	C11H15NO2
IUPAC name	1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine
Molecular weight	193.246
Hydrogen bond acceptor	3
Hydrogen bond donor	1
XlogP	2.2
Synonyms	CCRIS 9277 FT-0693477 LS-34696 Midomafetamine [USAN] Phenethylamine, N,alpha-dimethyl-3,4-methylenedioxy- [1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](methyl)amine (+-)-N-Methyl-3,4-(methylenedioxy)amphetamine 1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine 3,4-Methylenedioxy-N,alpha-dimethyl-beta-phenylethylamine 69610-10-2 CHEMBL43048 DivK1c_000962 I14-2777 MDMA (unspecified) NCGC00168266-01 SCHEMBL44210 (+/-)-MDMA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material 3,4-methylenedioxymethylamphetamine BDBM50010588 D0F5NJ Ecstasy (Drug) KE1SEN21RM Midomafetamine PDSP1_001522 XTC (+-)-(3,4-Methylenedioxy)methamphetamine 1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl- 54946-52-0 CHEBI:1391 DB01454 GTPL4574 Mandy [Street Name] N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine rac-3,4-Methylenedioxymethamphetamine (+/-)-(3,4-Methylenedioxy)methamphetamine 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine 3,4-Methylenedioxy-N-methylamphetamine (MDMA) AC1L1BUR CTK5D0599 DL-(3,4-Methylenedioxy)methamphetamine IDI1_000962 Methylenedioxy Methamphetamine NCGC00168266-02 SHXWCVYOXRDMCX-UHFFFAOYSA-N (RS)-3,4-(methylenedioxy)methamphetamine 42542-10-9 C07577 D11172 Epitope ID:178091 LS-34695 Midomafetamine (USAN/INN) PDSP2_001506 XTC [Street Name] (+-)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane 1,3-Benzodioxole-5-ethanamine,N,a-dimethyl- 64057-70-1 (hydrochloride) DEA No. 7405 HSDB 6929 N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE rac-MDMA (rac-3,4-Methylenedioxymethamphetamine) 1.0 mg/ml in Methanol (+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE 3,4-MDMA 3,4-methylenedioxymethamphetamine AKOS006283463 D0EX3I Ecstasy KBio1_000962 Methylenedioxymethamphetamine NINDS_000962 UNII-KE1SEN21RM ( inverted exclamation markA)-1,3-benzodioxolyl-N-methyl-2-propanamine( inverted exclamation markA)-3,4-methylenedioxy-N-methyl-\|A-methyl-2-phenethylamineDL-3,4-methylenedioxy-N-methylamphetaminemethylenedioxymethamphetamine [ Show all ]
Inchi Key	SHXWCVYOXRDMCX-UHFFFAOYSA-N
Inchi ID	InChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3
PubChem CID	1615
ChEMBL	CHEMBL43048
IUPHAR	N/A
BindingDB	50010588
DrugBank	DB01454
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
Ki	2532.0 nM	PMID12761331, http://pdsp.med.unc.edu/pdsp.php, http://molpharm.aspetjournals.org/cgi/content/full/63/6/1223	PDSP,BindingDB

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417